INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Corporate insider
TD

Torres Denice

DirectorCIK 0001820278

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score15
Connections2with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
TD
Torres DeniceDirector
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
26.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Celldex Therapeutics, Inc.Director · Jun 29, 2026
  • Insider ofevidence
    GLAUKOS CorpDirector · Jan 7, 2026
13
TD
Torres DeniceDirector
GKOSGLAUKOS Corp
Grant or award
A
—
1,878 sh
May 28, 2026
Jun 1, 2026
traded May 28, 2026
+4d
SEC FORM 4

Evidence

9
TD
Torres DeniceDirector
GKOSGLAUKOS Corp
Grant or award
A—
2,987 sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

15
TD
Torres DeniceDirector
GKOSGLAUKOS Corp
Grant or award
A—
623 sh
Jan 2, 2026Jan 7, 2026
traded Jan 2, 2026
+5dSEC FORM 4

Evidence